proqolid

Home > Instruments > Impact of Bronchiolitis Hospitalisation Questionnaire (IBHQ ©)

Impact of Bronchiolitis Hospitalisation Questionnaire (IBHQ ©)

Developed in 2008                                                                                                                                                                                            

Two modules:

- Impact of Bronchiolitis Hospitalisation Questionnaire-Discharge

- Impact of Bronchiolitis Hospitalisation Questionnaire-Follow-Up

Core items should be completed by all parents                                                           
Module items should be completed by parents in specific situations only

             

Author(s)

Abbott (France)

IBHQ © Abbott, 2008, All rights reserved

Purpose

  • Pathology:

Respiratory tract diseases

  • Disease:

Bronchiolitis

  • Objective:

To comprehensively assess the impact of bronchiolitis hospitalization on parents, both just after hospital discharge and three months after hospital discharge

  • Population for intended use:

Caregivers

[ Parents whose child has been hospitalized for bronchiolitis ]

 

Characteristics

  • Type of instrument:

Health-Related Quality of Life - HRQL (incl. health status)

  • Administration mode:

Self-administered

  • Data collection mode:

Paper and pen

  • Number of items:

IBHQ-DC and IBHQ-FU: Core: 30 items Module: 16 items

  • Recall/Observation period:

During your child's hospitalization for bronchiolitis (IBHQ-DC)
Since your child's hospitalization for bronchiolitis (IBHQ-FU)

 

Bibliographic reference(s) of the original questionnaire

Lapillonne A, Regnault A, Gournay V, Gouyon JB, Benmedjahed K, Anghelescu D, Arnould B, Moriette G. Development of a questionnaire to assess the impact on parents of their infant's bronchiolitis hospitalization. BMC Health Serv Res. 2013 Jul 12;13(1):272 (Full Text article)

Language(s)

  • Original language:

French for France

  • List of existing translations:

The translations listed below may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
This list of translations is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

IBHQ-DC

English for the USA*

* Performed by Mapi

Note: The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please contact our Information Support Unit.

Performing new translations

Review copy

This examination copy can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.

You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust.

To access this information, please sign in or subscribe to PROQOLID database

To access this information, please sign in or subscribe to PROQOLID database

To access this information, please sign in or subscribe to PROQOLID database

To access this information, please sign in or subscribe to PROQOLID database

To access this information, please sign in or subscribe to PROQOLID database

Contact information

Mapi Research Trust
Information Support Unit
27 rue de la Villette
69003 Lyon
France
Telephone: +33 (0)4 72 13 65 75
Fax: +33 (0)4 72 13 66 82
Email: PROinformation@mapi-trust.org

Conditions of use

Academic users

  • Non-Funded Studies: For use of the original/US English version in non-funded studies, please use our free online distribution service at the bottom of this page.
  • For other language versions or funded studies:

    • Complete and sign the User Agreement Special Terms which you will find below and also consult Mapi Research Trust’s User Agreement General Terms.
    • Return the completed, dated and executed User Agreement to Mapi Research Trust by post. Your request will be processed upon receipt.

    Note: A scanned copy may also be accepted to speed up the process as long as it is signed and that the original signed hard copy is also sent by regular mail, as we need it for our records.

Commercial Users

  • Complete and sign the User Agreement Special Terms which you will find below and also consult Mapi Research Trust’s User Agreement General Terms.
  • Return the completed, dated and executed User Agreement to Mapi Research Trust by post. Your request will be processed upon receipt.

Note: A scanned copy may also be accepted to speed up the process as long as it is signed and that the original signed hard copy is also sent by regular mail, as we need it for our records.


Access fees

ROYALTY FEES * Commercial users Cost per study Free
Cost per language Free
Funded academic research Cost per study Free
Cost per language Free
Not funded academic users Cost per study Free
Cost per language Free
DISTRIBUTION FEES * Commercial users Cost per study 700 €
Cost per language 300 €
Funded academic research Cost per study 300 €
Cost per language 50 €
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT

  • Commercial users: Industry, CRO, any for-profit companies
  • Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
  • Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Existence of a scoring / Interpretation / user manual

Yes, please contact Mapi Research Trust

Online Distribution for Non-Funded Academic Users

 

                                                 
The following licensing process is restricted to academic users:
  • Who do not receive specific funding for the study
  • Who intend to use the questionnaire in individual clinical practice or research study

 

If you DO NOT correspond to this category of users, you are not allowed to proceed further

Last update: October 2013

Last update in collaboration with the author: August 2013

  

For additional information on this instrument, please contact our Information Support Unit